Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. - Wikidata - wikimedia - TriplyDB

Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis.

Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis.

http://www.wikidata.org/entity/Q40414255

about

Current approaches to renovascular hypertension The current status of angioplasty of atherosclerotic renal artery stenosis for the treatment of hypertension Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension.Attending rounds: a patient with accelerated hypertension and an atrophic kidney Use of renin-angiotensin inhibitors in people with renal artery stenosis Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.The current state of endovascular therapy in the evaluation and management of renovascular disease.Renovascular hypertension and ischemic nephropathy.Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling.Hypertension in chronic kidney disease: navigating the evidence.ESRD and death after heart failure in CKD.Statins and renovascular disease in the elderly: a population-based cohort study.The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study.Efficacy of percutaneous transluminal renal angioplasty with stent in elderly male patients with atherosclerotic renal artery stenosis Low ankle-brachial index and the development of rapid estimated GFR decline and CKD Inflammatory and injury signals released from the post-stenotic human kidney Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin.Clinical practice. Renal-artery stenosis.Endovascular versus medical therapy for atherosclerotic renovascular disease Long-Term Outcomes and Causes of Death in Patients With Renovascular Disease Undergoing Renal Artery Stenting Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis.Diagnosis and management of renovascular disease and renovascular hypertension.Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.Embolic protection device use in renal artery stent placement Redox signaling is an early event in the pathogenesis of renovascular hypertension.Clinical and subclinical cardiovascular disease and kidney function decline in the elderly.The uncertain value of renal artery interventions: where are we now?Approach to atherosclerotic renovascular disease: 2016.Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate.Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis.Revascularization as a treatment to improve renal function.Cardiac function in renovascular hypertensive patients with and without renal dysfunction.Renal vascular structure and rarefaction.Cardiovascular morbidity and mortality and renal artery stenosis.Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension.Acute kidney injury in patients with decompensated heart failure.Contemporary management of atherosclerotic renovascular disease: before and after ASTRAL.The management of atherosclerotic renovascular disease.

P2860

Q24646720-B235D5BE-16A2-467A-84B2-33AB69D8ACCB Q26821947-6B7F035D-FDB5-409A-84E4-72A5BD691890 Q33594507-067F2850-5C89-4DF5-BF56-A593752D038F Q33715811-D53489C8-9B95-4493-982F-C88B2D41353C Q33835760-7E5D8DB9-2062-4438-AB54-04FC935A9819 Q34417974-1AF13F55-581E-42CF-A5E7-261C8179B5F8 Q34563720-0E7435E8-B1A4-489E-9E0C-3290A2CD80D6 Q34807128-28B4E381-6F79-46F6-918E-E3B0D4C0175D Q35057138-A2C13875-C774-4B1F-8CE5-756D2A431079 Q35071147-FCE8E186-7E7E-4321-A1F8-982265594E62 Q35124257-3D3CBC27-DA19-44DD-835F-588219395A8F Q35670027-2FF49B9A-CA1C-4C76-A62A-8F37EF5F6CD5 Q36215230-57BE472B-9E33-4880-B310-713FB475D4E0 Q36321501-DD99C283-B83E-459A-BA89-D1BFAB0B5032 Q36326394-A02202FE-226E-4DB8-B1A4-569AE1735B57 Q36454455-9CA17208-F638-452C-B5AE-DFE667C06E6C Q36609944-761C2562-9D17-4C52-A357-089B88BCCDFE Q36638400-BA111DEE-84EE-44FF-B6A6-6608AAB9ACEE Q36740975-A3B4216D-C786-48E9-BCA4-24D76465AAF4 Q36741879-B878CAD0-3C9F-49D3-9D93-3F400F812E9C Q36760787-34634751-BB50-47D9-AA75-2C860C96875C Q36763974-1DE330D8-4888-4DC1-AE3C-01E22F51478A Q36791992-F17554AC-5653-4A54-8902-D4ABFBD63ADD Q36814270-1728BA97-688B-4806-97EF-4AB3F3DC2075 Q37092395-57FBD8AE-3C4D-4AC2-A956-E55988F7C2BE Q37118448-D03A85CB-A8B8-4699-8E67-F4B22E93D63F Q37225203-621F9D0C-5F75-4247-A41E-E138C72CE1FA Q37228758-84061303-DDFF-4985-A293-B74C82E7D721 Q37269888-8A80FFCA-24AA-40B7-AD9D-294E30CDCA1F Q37284128-8BD8C5BF-9894-4BE2-AF85-C3A9A2A22FED Q37317861-1AB8C9BA-0898-4032-9364-6B00427EDC8A Q37542824-D8D604B7-16C5-4150-8C02-1B5578BDA8A0 Q37601238-CFC6B9C8-80E1-443B-BD14-2E9C13EB60AD Q37603629-863133B5-E0A8-442A-B726-F764F75C7280 Q37605855-D5DB20F5-272D-4987-975E-CE5BB76A54DC Q37633683-88CC5DFB-C894-4D07-9AB0-B6F192FC9615 Q37686149-1ECD14E7-EB46-4127-9F00-32308551865A Q37744472-F8B24626-07CC-4397-978E-A4660EF81A24 Q37873966-91B64AA7-12A0-4EAD-83FB-A0F81CD28D3F Q37892315-C23FC2F5-7AAB-4754-9B77-E02538BEAD20

P2860

Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis.

http://www.wikidata.org/entity/Q40414255

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Atherosclerotic renovascular d ...... ascularization, and prognosis.

@en

type

label

Atherosclerotic renovascular d ...... ascularization, and prognosis.

@en

prefLabel

Atherosclerotic renovascular d ...... ascularization, and prognosis.

@en

P1433

Q40414255-D54EAA1D-281D-430F-91AA-EDF3BB5035F6

P1476

Q40414255-0AB66648-2516-409E-8D19-4929161FF6CF

P2093

Q40414255-1B0502B9-0923-42D0-9539-8B6C1C5EDEC0

Q40414255-5F2D2598-A558-41C2-81F2-4C6934B9ECFB

Q40414255-696E6E7C-7373-4133-8A52-B1C5A891BBFF

Q40414255-9D28329F-4781-450A-9FFA-8A0D10948C01

Q40414255-A8FBF46F-8BEC-4FBB-B6C0-263A5AD44B29

Q40414255-BE8967CE-E078-427D-A534-D4B218A17B75

Q40414255-C4508E12-7E31-4D70-B76D-CB70F01CEC0F

Q40414255-CCB64975-BC97-4D56-A088-74644266B5FD

Q40414255-EC586FA5-B7C6-48F5-BE9A-36BEBA8F6B6A

P2888

Q40414255-AB72E707-19A7-4DE7-B488-389CFE976E76

P304

Q40414255-9A0549E0-C340-41AF-ADCE-E8211A755780

P31

Q40414255-B2FB284A-75F3-4418-9025-12FD7641E28B

P356

Q40414255-13E6DF67-EBDF-4840-9E3D-68B38F673FC9

P407

Q40414255-17C3F83F-2748-4705-B425-3A6CDAD2B8CD

P433

Q40414255-36864591-1718-4C67-9609-EE02FC6DE8A8

P478

Q40414255-882289B8-561B-4DAA-8EF5-D6EC89D55A80

P577

Q40414255-10E6D7E7-507D-4458-9B11-C1AEF6F93972

P5875

Q40414255-4E17B7CE-BFD4-4980-8938-28DBC7A34F53

P6179

Q40414255-178238DA-C604-4C72-8F4B-3B37BEE23020

P698

Q40414255-A68289B2-D6D3-4F35-98DD-077DF3DFACF5

P921

Q40414255-0C77C5DF-1EE1-4197-AB01-A51C43944DFE

Q40414255-D5D8884B-D670-40AD-B0EB-07EF633B8211

Q40414255-DF638B16-6EB5-4BBD-853B-C18245E66D04

P356

J.1523-1755.2005.00406.X

P1433

Kidney International

P1476

Atherosclerotic renovascular d ...... ascularization, and prognosis.

@en

P2093

Allan J Collins

http://www.w3.org/2001/XMLSchema#string

Annamaria T Kausz

http://www.w3.org/2001/XMLSchema#string

Areef Ishani

http://www.w3.org/2001/XMLSchema#string

David T Gilbertson

http://www.w3.org/2001/XMLSchema#string

Haifeng Guo

http://www.w3.org/2001/XMLSchema#string

Jiannong Liu

http://www.w3.org/2001/XMLSchema#string

Philip A Kalra

http://www.w3.org/2001/XMLSchema#string

Robert N Foley

http://www.w3.org/2001/XMLSchema#string

Shu-Cheng Chen

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2005.00406.x

P304

293-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1523-1755.2005.00406.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7787755

http://www.w3.org/2001/XMLSchema#string

P6179

1031508452

http://www.w3.org/2001/XMLSchema#string

P698

15954920

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

Ameeriga Ütisriigiq

revascularization